Suraksha Diagnostic IPO allotment: Check status, GMP, likely listing gain

Once the allotment is finalised, investors can check the allotment status by visiting the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

IPO
Kumar Gaurav New Delhi
3 min read Last Updated : Dec 04 2024 | 12:20 PM IST

Don't want to miss the best from Business Standard?

Suraksha Diagnostic IPO allotment today: The basis of allotment for Suraksha Diagnostic IPO shares is scheduled for today, Wednesday, December 4, 2024. The three-day subscription window to bid for the Suraksha Diagnostic IPO closed yesterday, receiving subdued participation from investors.
 
The Rs 846.25 crore public offering of Suraksha Diagnostic, available at a price band of Rs 420-441 with a lot size of 34 shares, received bids for 1,70,65,280 shares against the 1,34,32,533 shares on offer, resulting in an oversubscription of 1.27 times by the last date of subscription, as per BSE data.
 
Suraksha Diagnostic IPO final subscription status
Qualified institutional Buyers (QIBs) placed the highest bids for the Suraksha Diagnostic IPO, with a subscription rate of 1.74 times, followed by Non-Institutional Investors (NIIs) at 1.41 times, and retail investors at 0.95 times.  ALSO READ: Ganesh Infraworld IPO allotment
   
Suraksha Diagnostic IPO allotment status
The shares of Suraksha Diagnostic are scheduled to be allotted today. Once the allotment is finalised, investors can check the allotment status by visiting the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue. Alternatively, investors can use the following links to check the allotment status directly:
 
Check Suraksha Diagnostic IPO allotment status on BSE: https://www.bseindia.com/investors/appli_check.aspx
 
Check Suraksha Diagnostic IPO allotment status on Kfin Technologies: https://ipostatus.kfintech.com/
 
Check Suraksha Diagnostic IPO allotment status on NSE: https://www.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp
 
Suraksha Diagnostic IPO grey market premium (GMP) today
The grey market premium (GMP) for the unlisted shares of Suraksha Diagnostic has remained flat since the launch of its public offering. The company's shares were trading at Rs 443 in the grey markets, reflecting a premium of Rs 2, or 0.45 per cent, against the upper end of the IPO price band, revealed sources tracking unofficial markets.
 
Suraksha Diagnostic expected listing price
Shares of Suraksha Diagnostic are scheduled to list on the BSE and NSE on Friday, December 6, 2024. Taking current grey market trends into consideration, Suraksha Diagnostic shares may list at around Rs 443 (IPO GMP + Upper price band). However, this may change, given that the grey markets are unregulated.
 
About Suraksha Diagnostic
Established in 2005 and headquartered in Kolkata, Suraksha Diagnostic (SDL) is a provider of integrated diagnostic services catering to key regions in India, including West Bengal, Bihar, Assam, and Meghalaya. The company offers a comprehensive range of pathology, radiology, and specialised diagnostic solutions.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :IPO allotmentIPO GMPIPO listing timeIPO REVIEWIPOsinitial public offerings IPOsshare market

First Published: Dec 04 2024 | 8:31 AM IST

Next Story